Drawing for THE TBI EVALUATION STATION

USPTO serial 90008926

THE TBI EVALUATION STATION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FITZSIMONS, MICHAEL R
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE TBI EVALUATION STATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan K. Bowen

Megan K. Bowen Edell, Shapiro & Finnan, LLC9801 WASHINGTONIAN BOULEVARD, SUITE 750GAITHERSBURG, MD 20878United States

Goods and services

ClassDescriptionStatusFirst use
005Clinical and in vitro diagnostic reagents for medical use; Clinical and in vitro diagnostic reagents for medical use, namely, immunoassay test kits, consisting primarily of in vitro reagents for the diagnosis, prognosis, and monitoring of conditions of physiological significance; Clinical and in vitro diagnostic reagents for medical diagnostic assay kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids, for medical diagnosis; Medical diagnostic assay test kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluidsACTIVE—
009Computer hardware; downloadable software and downloadable mobile applications for use in the diagnosis, prognosis, and monitoring of brain and head trauma and injury through the analysis of diagnostic reagents; downloadable software and downloadable mobile applications for assessing physiologic measures, performing behavioral, psychological, vestibular and ocular motility based neuro-diagnostic tests, for accessing data, reports, and summaries of patient autonomic nervous system testing, and for reporting a combined multi-modality score for the diagnosis, prognosis and monitoring of brain and head trauma and injuryACTIVE—
010Medical testing devices for measuring disease markers, in the fields of immunoassays, and molecular diagnostics, including the use of an assay test panel, composed of one or more brain-enriched biomarkers, and for measuring blood flow and imaging for the purposes of identifying, testing for, detecting, monitoring, and reporting on brain and head trauma and injuryACTIVE—
044Medical testing and assessment services, for the testing, evaluation, analysis and reporting of patient results associated with brain and head trauma and injury from multi-modalities for diagnostic and medical testing purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 4, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 4, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2023EX5GSOU EXTENSION 5 GRANTED—
Jul 27, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 19, 2023EXT5SOU EXTENSION 5 FILED—
Jul 19, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2023EX4GSOU EXTENSION 4 GRANTED—
Jan 9, 2023EXT4SOU EXTENSION 4 FILED—
Jan 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2022EX3GSOU EXTENSION 3 GRANTED—
Jul 28, 2022EXT3SOU EXTENSION 3 FILED—
Jul 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 1, 2022EX2GSOU EXTENSION 2 GRANTED—
Feb 1, 2022EXT2SOU EXTENSION 2 FILED—
Feb 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 26, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 26, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 26, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2021EX1GSOU EXTENSION 1 GRANTED—
Jul 28, 2021EXT1SOU EXTENSION 1 FILED—
Jul 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 29, 2021DOCKASSIGNED TO EXAMINER—
Feb 2, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 8, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 8, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 18, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 2, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2020DOCKASSIGNED TO EXAMINER—
Jul 16, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 22, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance